Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Outcome of Patients With CBF and/or NPM1-mutated AML in First Molecular Relapse.

NCT04931992 is registered in ClinicalTrials.gov with University Hospital, Angers as lead sponsor.

NCT NCT04931992
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04931992 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Outcome of Patients With CBF and/or NPM1-mutated AML in First Molecular Relapse.
Lead sponsor
University Hospital, Angers
Phase
Observational
Overall status
Unknown status
Start date
June 1, 2021
Completion date
December 31, 2021
Enrollment
100 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

acute myeloid leukemia